Joel Androphy won a settlement with Pfizer in a qui tam action in U.S. District Court

Joel Androphy won a settlement with Pfizer in a qui tam action in U.S. District Court. The case involved the underpayment of medicaid rebates, false claims and best price violations for the drug Lipitor. The settlement netted the client and government about $46 million.

For more information see the Wall Street Journal, Washington Post, National Law Journal and other major news archives for October 29, 2002.